INNIO N.V. Ordinary Shares vs MiniMed Group Inc. Common Stock — how do they compare? INNIO N.V. Ordinary Shares trades at $15.9 (market cap $12.38B), while MiniMed Group Inc. Common Stock trades at $16.74 (market cap $4.73B). The key difference: INNIO N.V. Ordinary Shares is far larger — about 2.6× MiniMed Group Inc. Common Stock's market cap, and MiniMed Group Inc. Common Stock is trading nearer its 52-week high, INNIO N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold INNIO N.V. Ordinary Shares for 0 Days and MiniMed Group Inc. Common Stock for 6 Days on average.
| INIO | MMED | |
|---|---|---|
Market Cap | $12.38B | $4.73B |
Volume | 6,733,708 | 67,620,827 |
Sector | Industrials | Health |
52-Week High | $41.13 | $23.84 |
52-Week Low | $16.50 | $10.80 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $14.04B | $4.53B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MMED trades at $18.40, down 2.13% today, with technical indicators showing bearish momentum. The company reported revenue growth to $2.72B in 2025 but posted a net loss of -$250M. Recent news highlights Medtronic's exchange offer completion and MiniMed's new product launches. Analyst consensus remains strongly bullish with 100% buy ratings and a $25.73 price target, representing 40% upside potential from current levels.
Despite negative profitability metrics and bearish technical signals, MMED maintains strong analyst support and revenue growth trajectory. Key risks include persistent net losses, high short interest, and execution challenges in the competitive diabetes technology market. The stock offers potential upside if new product cycles drive margin improvement and profitability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
INNIO Group designs, manufactures, and services reciprocating gas engines for distributed power generation under its Jenbacher and Waukesha brands, serving applications from data centers to industrial and grid-stabilization uses.
Read more on INIO →MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →